nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinacrine—PLA2G4A—Fluocinolone Acetonide—psoriasis	0.624	0.641	CbGbCtD
Quinacrine—CYP3A5—Beclomethasone—psoriasis	0.0627	0.0644	CbGbCtD
Quinacrine—CYP3A5—Mycophenolate mofetil—psoriasis	0.025	0.0256	CbGbCtD
Quinacrine—CYP3A4—Calcitriol—psoriasis	0.0218	0.0224	CbGbCtD
Quinacrine—CYP3A5—Hydrocortisone—psoriasis	0.02	0.0206	CbGbCtD
Quinacrine—CYP3A5—Cyclosporine—psoriasis	0.0189	0.0194	CbGbCtD
Quinacrine—CYP3A4—Methoxsalen—psoriasis	0.017	0.0174	CbGbCtD
Quinacrine—ABCB1—Mycophenolate mofetil—psoriasis	0.0162	0.0167	CbGbCtD
Quinacrine—ABCB1—Betamethasone—psoriasis	0.0139	0.0143	CbGbCtD
Quinacrine—ABCB1—Prednisolone—psoriasis	0.0138	0.0141	CbGbCtD
Quinacrine—ABCB1—Hydrocortisone—psoriasis	0.013	0.0134	CbGbCtD
Quinacrine—ABCB1—Prednisone—psoriasis	0.013	0.0133	CbGbCtD
Quinacrine—CYP3A5—Dexamethasone—psoriasis	0.0125	0.0128	CbGbCtD
Quinacrine—ABCB1—Cyclosporine—psoriasis	0.0123	0.0126	CbGbCtD
Quinacrine—CYP3A4—Cholecalciferol—psoriasis	0.0112	0.0115	CbGbCtD
Quinacrine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00974	0.01	CbGbCtD
Quinacrine—CYP3A4—Triamcinolone—psoriasis	0.00974	0.01	CbGbCtD
Quinacrine—CYP3A4—Betamethasone—psoriasis	0.00835	0.00858	CbGbCtD
Quinacrine—CYP3A4—Prednisolone—psoriasis	0.00824	0.00846	CbGbCtD
Quinacrine—ABCB1—Dexamethasone—psoriasis	0.00811	0.00833	CbGbCtD
Quinacrine—CYP3A4—Hydrocortisone—psoriasis	0.00781	0.00802	CbGbCtD
Quinacrine—CYP3A4—Prednisone—psoriasis	0.00778	0.00799	CbGbCtD
Quinacrine—CYP3A4—Cyclosporine—psoriasis	0.00738	0.00758	CbGbCtD
Quinacrine—ABCB1—Methotrexate—psoriasis	0.00652	0.00669	CbGbCtD
Quinacrine—CYP3A4—Dexamethasone—psoriasis	0.00486	0.00499	CbGbCtD
Quinacrine—PLA2G4A—Raltitrexed—Methotrexate—psoriasis	0.00167	0.291	CbGdCrCtD
Quinacrine—Chloroquine—TNF—psoriasis	0.00149	1	CrCbGaD
Quinacrine—HNMT—Metapathway biotransformation—CYP2S1—psoriasis	0.00133	0.0704	CbGpPWpGaD
Quinacrine—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000871	0.0463	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL22—psoriasis	0.000528	0.028	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—IL4—psoriasis	0.000413	0.0219	CbGpPWpGaD
Quinacrine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000405	0.0215	CbGpPWpGaD
Quinacrine—PLA2G4A—Dexamethasone—Clobetasol propionate—psoriasis	0.000394	0.0686	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Clobetasol propionate—psoriasis	0.000394	0.0686	CbGdCrCtD
Quinacrine—PLA2G6—Immune System—KIR2DS1—psoriasis	0.00038	0.0202	CbGpPWpGaD
Quinacrine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000362	0.0192	CbGpPWpGaD
Quinacrine—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000357	0.019	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—LEP—psoriasis	0.000349	0.0185	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—ICAM1—psoriasis	0.000328	0.0174	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—NOS2—psoriasis	0.000325	0.0173	CbGpPWpGaD
Quinacrine—PLA2G4A—Dexamethasone—Fluocinonide—psoriasis	0.000316	0.0549	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Beclomethasone—psoriasis	0.000316	0.0549	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Fluocinonide—psoriasis	0.000316	0.0549	CbGdCrCtD
Quinacrine—PLA2G4A—Dexamethasone—Beclomethasone—psoriasis	0.000316	0.0549	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000307	0.0534	CbGdCrCtD
Quinacrine—PLA2G4A—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000307	0.0534	CbGdCrCtD
Quinacrine—PLA2G6—Innate Immune System—DDX58—psoriasis	0.000294	0.0156	CbGpPWpGaD
Quinacrine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000293	0.0156	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—IFNG—psoriasis	0.00025	0.0132	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.00024	0.0128	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—SERPINB8—psoriasis	0.000238	0.0126	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—CXCL8—psoriasis	0.000232	0.0123	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—NDUFA5—psoriasis	0.000223	0.0118	CbGpPWpGaD
Quinacrine—PLA2G4A—PDGF Pathway—NFKBIA—psoriasis	0.000221	0.0117	CbGpPWpGaD
Quinacrine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000218	0.0116	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000208	0.011	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—IFIH1—psoriasis	0.000202	0.0107	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—ERAP1—psoriasis	0.000195	0.0103	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—HLA-C—psoriasis	0.000192	0.0102	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—TNFAIP3—psoriasis	0.000189	0.0101	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—CYP2S1—psoriasis	0.000189	0.01	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000181	0.00959	CbGpPWpGaD
Quinacrine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000174	0.00925	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—DDX58—psoriasis	0.000171	0.00909	CbGpPWpGaD
Quinacrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000168	0.00893	CbGpPWpGaD
Quinacrine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000166	0.00881	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—TNF—psoriasis	0.000162	0.00858	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000159	0.00846	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—HLA-E—psoriasis	0.000159	0.00845	CbGpPWpGaD
Quinacrine—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000156	0.00827	CbGpPWpGaD
Quinacrine—PLA2G4A—Dexamethasone—Hydrocortisone—psoriasis	0.000155	0.027	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Hydrocortisone—psoriasis	0.000155	0.027	CbGdCrCtD
Quinacrine—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000154	0.00816	CbGpPWpGaD
Quinacrine—PLA2G4A—PDGF Pathway—JUN—psoriasis	0.000146	0.00776	CbGpPWpGaD
Quinacrine—PLA2G4A—AGE/RAGE pathway—NOS2—psoriasis	0.000145	0.00768	CbGpPWpGaD
Quinacrine—PLA2G4A—AGE/RAGE pathway—NFKBIA—psoriasis	0.000145	0.00768	CbGpPWpGaD
Quinacrine—PLA2G4A—Dexamethasone—Betamethasone—psoriasis	0.000144	0.025	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Dexamethasone—psoriasis	0.000144	0.025	CbGdCrCtD
Quinacrine—PLA2G6—Spinal Cord Injury—TP53—psoriasis	0.000142	0.00756	CbGpPWpGaD
Quinacrine—PLA2G4A—Dexamethasone—Triamcinolone—psoriasis	0.000141	0.0245	CbGdCrCtD
Quinacrine—PLA2G4A—Betamethasone—Triamcinolone—psoriasis	0.000141	0.0245	CbGdCrCtD
Quinacrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000136	0.00724	CbGpPWpGaD
Quinacrine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000135	0.00714	CbGpPWpGaD
Quinacrine—PLA2G4A—Betamethasone—Prednisone—psoriasis	0.000133	0.0232	CbGdCrCtD
Quinacrine—PLA2G4A—Dexamethasone—Prednisone—psoriasis	0.000133	0.0232	CbGdCrCtD
Quinacrine—PLA2G6—Innate Immune System—SOCS1—psoriasis	0.000133	0.00706	CbGpPWpGaD
Quinacrine—PLA2G6—Spinal Cord Injury—IL6—psoriasis	0.00013	0.00692	CbGpPWpGaD
Quinacrine—PLA2G4A—Betamethasone—Prednisolone—psoriasis	0.00013	0.0227	CbGdCrCtD
Quinacrine—PLA2G4A—Dexamethasone—Prednisolone—psoriasis	0.00013	0.0227	CbGdCrCtD
Quinacrine—PLA2G6—Immune System—ITGAL—psoriasis	0.00013	0.00689	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.00013	0.00687	CbGpPWpGaD
Quinacrine—PLA2G4A—Platelet homeostasis—NOS2—psoriasis	0.000127	0.00672	CbGpPWpGaD
Quinacrine—PLA2G4A—PDGF Pathway—STAT3—psoriasis	0.000126	0.00671	CbGpPWpGaD
Quinacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000125	0.00666	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—REL—psoriasis	0.000121	0.00644	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—IFIH1—psoriasis	0.000118	0.00625	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—HLA-B—psoriasis	0.000113	0.00602	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—HLA-C—psoriasis	0.000112	0.00593	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—TNFAIP3—psoriasis	0.00011	0.00586	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000105	0.00559	CbGpPWpGaD
Quinacrine—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—psoriasis	0.000102	0.00543	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—CRP—psoriasis	0.0001	0.00532	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.0001	0.00531	CbGpPWpGaD
Quinacrine—PLA2G4A—Endothelins—JUN—psoriasis	9.96e-05	0.00529	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL13—psoriasis	9.94e-05	0.00527	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.92e-05	0.00527	CbGpPWpGaD
Quinacrine—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—psoriasis	9.84e-05	0.00522	CbGpPWpGaD
Quinacrine—PLA2G4A—AGE/RAGE pathway—JUN—psoriasis	9.6e-05	0.00509	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—HLA-E—psoriasis	9.27e-05	0.00492	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—CARM1—psoriasis	9.25e-05	0.00491	CbGpPWpGaD
Quinacrine—PLA2G4A—AGE/RAGE pathway—NFKB1—psoriasis	9.24e-05	0.0049	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL17A—psoriasis	9.14e-05	0.00485	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—NFKBIA—psoriasis	9.14e-05	0.00485	CbGpPWpGaD
Quinacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.74e-05	0.00464	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.64e-05	0.00459	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL12B—psoriasis	8.5e-05	0.00451	CbGpPWpGaD
Quinacrine—PLA2G4A—AGE/RAGE pathway—STAT3—psoriasis	8.3e-05	0.00441	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.3e-05	0.0044	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—HCAR2—psoriasis	8.28e-05	0.00439	CbGpPWpGaD
Quinacrine—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	7.92e-05	0.0042	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—SOCS1—psoriasis	7.74e-05	0.00411	CbGpPWpGaD
Quinacrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.73e-05	0.0041	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—TYK2—psoriasis	7.49e-05	0.00397	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.36e-05	0.00391	CbGpPWpGaD
Quinacrine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.24e-05	0.00384	CbGpPWpGaD
Quinacrine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.14e-05	0.00379	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—ITGAL—psoriasis	6.92e-05	0.00367	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—CD8A—psoriasis	6.87e-05	0.00365	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.87e-05	0.00364	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—CD4—psoriasis	6.77e-05	0.00359	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—HLA-B—psoriasis	6.61e-05	0.00351	CbGpPWpGaD
Quinacrine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.25e-05	0.00332	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—NDUFA5—psoriasis	6.22e-05	0.0033	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL10—psoriasis	6.22e-05	0.0033	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.19e-05	0.00328	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—HLA-A—psoriasis	6.12e-05	0.00325	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—JUN—psoriasis	6.06e-05	0.00322	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IL4—psoriasis	6.05e-05	0.00321	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.91e-05	0.00314	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.9e-05	0.00313	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—CRP—psoriasis	5.84e-05	0.0031	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—NFKB1—psoriasis	5.83e-05	0.0031	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.8e-05	0.00308	CbGpPWpGaD
Quinacrine—PLA2G4A—PDGFR-beta signaling pathway—JUN—psoriasis	5.76e-05	0.00306	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—CAT—psoriasis	5.69e-05	0.00302	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—HLA-DRB1—psoriasis	5.59e-05	0.00297	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.5e-05	0.00292	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.48e-05	0.00291	CbGpPWpGaD
Quinacrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.39e-05	0.00286	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—ICAM1—psoriasis	5.37e-05	0.00285	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—NFKBIA—psoriasis	5.33e-05	0.00283	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—CYP2S1—psoriasis	5.29e-05	0.00281	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5e-05	0.00266	CbGpPWpGaD
Quinacrine—PLA2G4A—PDGFR-beta signaling pathway—STAT3—psoriasis	4.98e-05	0.00264	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—HCAR2—psoriasis	4.89e-05	0.0026	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—APOE—psoriasis	4.42e-05	0.00235	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—TYK2—psoriasis	4.36e-05	0.00231	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—NDUFA5—psoriasis	4.33e-05	0.0023	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—CCL20—psoriasis	4.3e-05	0.00228	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—TAGAP—psoriasis	4.24e-05	0.00225	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.1e-05	0.00218	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—IFNG—psoriasis	4.08e-05	0.00217	CbGpPWpGaD
Quinacrine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.02e-05	0.00214	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.95e-05	0.0021	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—CD4—psoriasis	3.94e-05	0.00209	CbGpPWpGaD
Quinacrine—PLA2G6—Metabolism—PPARG—psoriasis	3.85e-05	0.00204	CbGpPWpGaD
Quinacrine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.84e-05	0.00204	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—CYP2S1—psoriasis	3.68e-05	0.00195	CbGpPWpGaD
Quinacrine—PLA2G6—Innate Immune System—IL6—psoriasis	3.66e-05	0.00194	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.65e-05	0.00194	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.65e-05	0.00194	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.58e-05	0.0019	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—JUN—psoriasis	3.53e-05	0.00187	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—NFKB1—psoriasis	3.4e-05	0.0018	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.4e-05	0.0018	CbGpPWpGaD
Quinacrine—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	3.19e-05	0.00169	CbGpPWpGaD
Quinacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.19e-05	0.00169	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—NDUFA5—psoriasis	3.13e-05	0.00166	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.07e-05	0.00163	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—STAT3—psoriasis	3.05e-05	0.00162	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—NOS2—psoriasis	2.84e-05	0.00151	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.8e-05	0.00149	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.77e-05	0.00147	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.76e-05	0.00146	CbGpPWpGaD
Quinacrine—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.71e-05	0.00144	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—CYP2S1—psoriasis	2.66e-05	0.00141	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—CARM1—psoriasis	2.58e-05	0.00137	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—CCL20—psoriasis	2.54e-05	0.00135	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.41e-05	0.00128	CbGpPWpGaD
Quinacrine—ABCB1—Allograft Rejection—TNF—psoriasis	2.37e-05	0.00126	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—NDUFA5—psoriasis	2.36e-05	0.00126	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.35e-05	0.00125	CbGpPWpGaD
Quinacrine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.2e-05	0.00117	CbGpPWpGaD
Quinacrine—PLA2G6—Immune System—IL6—psoriasis	2.13e-05	0.00113	CbGpPWpGaD
Quinacrine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.1e-05	0.00111	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—CYP2S1—psoriasis	2.01e-05	0.00107	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—CARM1—psoriasis	1.8e-05	0.000954	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—VEGFA—psoriasis	1.64e-05	0.000872	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—CAT—psoriasis	1.59e-05	0.000843	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.56e-05	0.000827	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.5e-05	0.000797	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.46e-05	0.000773	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—SOCS1—psoriasis	1.4e-05	0.000742	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.36e-05	0.000723	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—TYK2—psoriasis	1.33e-05	0.000708	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—CARM1—psoriasis	1.3e-05	0.000691	CbGpPWpGaD
Quinacrine—PLA2G4A—Hemostasis—TP53—psoriasis	1.24e-05	0.000659	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.24e-05	0.000658	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—APOE—psoriasis	1.23e-05	0.000655	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.17e-05	0.00062	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—CXCL8—psoriasis	1.16e-05	0.000616	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—CAT—psoriasis	1.11e-05	0.000587	CbGpPWpGaD
Quinacrine—PLA2G4A—Metabolism—PPARG—psoriasis	1.08e-05	0.000571	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—LEP—psoriasis	1.03e-05	0.000548	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—APOE—psoriasis	1.03e-05	0.000548	CbGpPWpGaD
Quinacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.03e-05	0.000546	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—CARM1—psoriasis	9.82e-06	0.000521	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—NFKBIA—psoriasis	9.62e-06	0.000511	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—APOE—psoriasis	8.59e-06	0.000456	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—CAT—psoriasis	8e-06	0.000425	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—TYK2—psoriasis	7.88e-06	0.000418	CbGpPWpGaD
Quinacrine—SLC22A2—Metabolism—PPARG—psoriasis	7.48e-06	0.000397	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—CXCL8—psoriasis	6.86e-06	0.000364	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling by GPCR—IL6—psoriasis	6.52e-06	0.000346	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—JUN—psoriasis	6.38e-06	0.000339	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—APOE—psoriasis	6.22e-06	0.00033	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—NFKB1—psoriasis	6.14e-06	0.000326	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—CARM1—psoriasis	6.05e-06	0.000321	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—CAT—psoriasis	6.04e-06	0.000321	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—VEGFA—psoriasis	5.57e-06	0.000296	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—STAT3—psoriasis	5.52e-06	0.000293	CbGpPWpGaD
Quinacrine—CYP3A5—Metabolism—PPARG—psoriasis	5.42e-06	0.000288	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—APOE—psoriasis	4.69e-06	0.000249	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—TP53—psoriasis	4.21e-06	0.000223	CbGpPWpGaD
Quinacrine—ABCB1—Metabolism—PPARG—psoriasis	4.09e-06	0.000217	CbGpPWpGaD
Quinacrine—PLA2G4A—Signaling Pathways—IL6—psoriasis	3.85e-06	0.000205	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—CAT—psoriasis	3.72e-06	0.000198	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—APOE—psoriasis	2.89e-06	0.000153	CbGpPWpGaD
Quinacrine—CYP3A4—Metabolism—PPARG—psoriasis	2.52e-06	0.000134	CbGpPWpGaD
